Pharmacogenetics for Genes Associated with Age-Related Macular Degeneration (AMD) in the Comparison of AMD Treatments Trials (CATT)

PURPOSE: To evaluate the pharmacogenetic relationship between genotypes of single nucleotide polymorphisms (SNPs) known to be associated with age-related macular degeneration (AMD) and response to treatment with ranibizumab (Lucentis) or bevacizumab (Avastin) for neovascular AMD. DESIGN: Clinical tr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hagstrom, Stephanie A, Ying, Gui-shuang, Pauer, Gayle JT, Sturgill-Short, Gwen M, Huang, Jiayan, Callanan, David G, Kim, Ivana K, Klein, Michael L, Maguire, Maureen G, Martin, Daniel F
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3633658/
https://ncbi.nlm.nih.gov/pubmed/23337555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2012.11.037
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi